Home › Multiple Sclerosis › Colorado › Fort Collins
Multiple Sclerosis clinical trials in Fort Collins, CO
3 studies for Multiple Sclerosis are looking for participants at sites in and around Fort Collins (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
RecruitingObservational study
- TG Therapeutics Investigational Trial Site, Fort Collins
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
RecruitingPhase 4
- Advanced Neurology of Colorado, LLC, Fort Collins
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
RecruitingPhase 3
- Advanced Neurology of Colorado- Site Number : 8400148, Fort Collins
About Multiple Sclerosis
Multiple sclerosis (MS) slows down or blocks messages between the brain and body. MS can be mild or severe. Learn about MS symptoms and treatment.
More about Multiple Sclerosis on MedlinePlus
Multiple Sclerosis trials in other cities
- New York City, NY17 studies
- Chicago, IL15 studies
- Boston, MA14 studies
- Washington, DC13 studies
- Cleveland, OH10 studies
- Birmingham, AL9 studies
- Aurora, CO8 studies
- Kansas City, KS8 studies
- St. Louis, MO8 studies
- San Francisco, CA8 studies
- Tampa, FL7 studies
- Dallas, TX7 studies
Other studies in Fort Collins
- Lung Cancer8 studies
- Breast Cancer6 studies
- Ovarian Cancer5 studies
- Prostate Cancer5 studies
- Non-Small Cell Lung Cancer5 studies
- Bladder Cancer4 studies
- Colon Cancer4 studies
- Metastatic Cancer3 studies
- Cancer (all types)3 studies
- Kidney Cancer (Renal Cell Carcinoma)3 studies
- Multiple Myeloma3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.